Table of Contents
Research & Development
Lilly Bolsters Diabetes Pipeline with KeyBioScience Collaboration | Abstract pdf html |
Natasha Piper |
Licensing
J & J Commits up to US$1 B for Protagonist’s Preclinical Crohn’s Disease Drug | Abstract pdf html |
Natasha Piper |
Pfizer Bolsters Anti-Infectives Presence with Basilea Deal | Abstract pdf html |
Natasha Piper |
Mergers & Acquisitions
Biogen Spin-Off Bioverativ to Acquire True North Therapeutics for up to US$825 M | Abstract html pdf |
Natasha Piper |

This work is licensed under a Creative Commons Attribution 3.0 License.